0000899243-20-018256.txt : 20200702 0000899243-20-018256.hdr.sgml : 20200702 20200702160227 ACCESSION NUMBER: 0000899243-20-018256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HealthCap VII, L.P. CENTRAL INDEX KEY: 0001645161 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39344 FILM NUMBER: 201009197 BUSINESS ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1000-1018 BUSINESS PHONE: 41 21 614 3500 MAIL ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1000-1018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HealthCap VII GP S.A. CENTRAL INDEX KEY: 0001790047 STATE OF INCORPORATION: V7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39344 FILM NUMBER: 201009199 BUSINESS ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1006 BUSINESS PHONE: 41-21-614 35 00 MAIL ADDRESS: STREET 1: 18 AVENUE D'OUCHY CITY: CH 1006 LAUSANNE STATE: V8 ZIP: 1006 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001805890 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 BUSINESS PHONE: 289-799-0891 MAIL ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-30 1 0001805890 Fusion Pharmaceuticals Inc. FUSN 0001645161 HealthCap VII, L.P. C/O HEALTHCAP VII GP S.A., 18 AVENUE OF D'OUCHY LAUSANNE V8 CH-1006 SWITZERLAND 0 0 1 0 0001790047 HealthCap VII GP S.A. C/O HEALTHCAP VII GP S.A., 18 AVENUE OF D'OUCHY LAUSANNE V8 CH-1006 SWITZERLAND 0 0 1 0 Common Shares 2020-06-30 4 C 0 2497345 A 2497345 I See Footnote Common Shares 2020-06-30 4 C 0 1069902 A 3567247 I See Footnote Common Shares 2020-06-30 4 P 0 240000 17.00 A 3807247 I See Footnote Class A Preferred Exchangeable Shares 2020-06-30 4 C 0 13333333 D Common Shares 2497345 0 I See Footnote Class B Preferred Exchangeable Shares 2020-06-30 4 C 0 5712216 D Common Shares 1069902 0 I See Footnote Represents Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemable into Class A Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class A Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class A Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis. The securities are directly held by HealthCap VII, L.P. ("HCLP"). HealthCap VII GP SA ("HCSA") is the sole general partner of HCLP and has voting and investment control over the Shares and Preferred Stock held by HCLP. Johan Christenson has an indirect interest in HCSA and is an employee of HealthCap VII Advisor AB. Each of the General Partner and Dr. Christenson disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that the General Partner or Dr. Christenson is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Represents Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited. The Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemable into Class B Preferred Shares of the Issuer. Upon the closing of the Issuer's initial public offering, the Class B Preferred Exchangeable Shares of Fusion Pharmaceuticals (Ireland) Limited were redeemed into Class B Preferred Shares of the Issuer on a one-for-one basis, which subsequently converted into Common Shares of the Issuer on a one-for-5.339 basis. /s/ HealthCap VII L.P., By: By: HealthCap VII GP S.A., its general partner, By: /s/ Dag Richter, Name: Dag Richter, Title: Director, and By: /s/ Fabrice Bernhard, Name: Fabrice Bernhard, Title: General Manager 2020-07-02 /s/ HealthCap VII GP S.A., By: /s/ Dag Richter, Name: Dag Richter, Title: Director, and By: /s/ Fabrice Bernhard, Name: Fabrice Bernhard, Title: General Manager 2020-07-02